
Company Profile
Baxter touches the lives of millions of people around the world every day. Our products and therapies can be found throughout hospitals and clinics – from the ER to the OR, from the pharmacy to the ICU – as well as advancing patients’ care in their homes. For more than 50 years, Baxter has had a presence and long standing commitment in the UK. We are one of the largest suppliers to the NHS with over 7,500 products and services. We work closely with healthcare organisations to empower patients to self-care and manage their care closer to home. We also collaborate with the NHS to help introduce new care pathways to bring cost and time efficiencies to the NHS. Baxter has 13 sites across the UK including our UK head office, three manufacturing facilities, a national distribution centre, two home care pharmacy distribution centres, four aseptic compounding facilities and two residential patient education centres. Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives.
Approach to Healthcare
We are leading global conversations to help improve and personalise healthcare. Insights from our patients, healthcare providers and community partners guide our efforts to deliver meaningful innovations that advance healthcare. We promise to foster innovation, strive for the highest standards of corporate responsibility and support an inclusive and diverse workplace to enable a better tomorrow.
Impact of Products/Services on Healthcare:
Our products help clinicians be more efficient and effective in treating patients at the hospital bedside, in the operating theatre, in the intensive care unit, at home and in the dialysis clinic. Our mission to save and sustain lives is reflected in our pioneering legacy and focus on patient-centred innovation. We are passionate about shaping the future and giving back to the communities where we live and work .Our global product portfolio enables clinicians to be more efficient and effective in treating patients at the hospital bedside, in the operating theatre, in critical care units, at home and in the dialysis clinic. We are working alongside our partners to find new and smarter ways to improve patient outcomes, prevent complications before they become life-threatening and increase access to care, while reducing total costs.
Innovation
To continue to transform and increase access to care for patients around the world, we are investing in new collaborations, partnering with world-renowned institutions, seeking out the next-generation of innovators in healthcare and funding the pursuit of new discoveries and research. We are dedicated to supporting the pioneering efforts of clinicians and scientists who are focused on innovative research, and continuing education for healthcare professionals. highest standards of corporate governance. Fuelling Collaborative Innovation. Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world’s most pressing healthcare challenges.
Future Direction
We invest in companies with innovative technologies, products and therapies that accelerate growth and advance patient care. Each investment opportunity undergoes a rigorous evaluation process to determine if it has the potential to address unmet clinical needs and offer sustainable long-term growth. Our investment focus includes therapeutic areas complementary to Baxter’s presence in critical, hospital, nutritional, renal and surgical care, as well as cutting-edge technology and therapies.